Who is eligible for clinical trial NCT03915431?

Participants must meet protocol criteria for Ischemic Stroke. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT03915431 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2025-09-04

A Study of NCS-01 in Patients With Acute Ischemic Stroke (NCT03915431)

A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic Sponsor: NC Medial Research Inc

🩺 Plain-English Summary (8th-Grade Level)

This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.

Who can join: Review the eligibility criteria below.

Location: University of Miami — Miami, Florida

Age range: 18 Years to 85 Years

🧪 Interventions in This Study

NCS-01 (BIOLOGICAL)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

University of Miami — Miami, Florida

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Ischemic Stroke

OsciPulse D-dimer Pilot Trial — Philadelphia, Pennsylvania
Memantine for Enhanced Stroke Recovery — Salt Lake City, Utah
Sleep for Stroke Management and Recovery Trial — Birmingham, Alabama
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Huntsville, Alabama
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) — Stanford, California
VNS-REHAB At-Home - Post-Market Study for Using the Vivistim System® at Home — Chicago, Illinois

Explore by condition: All Ischemic Stroke clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Review the official NIH record below to find the coordinating site.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗